Pharmafile Logo
Pharmafocus logo
Advanced Search
drug-trials

BioNet receives positive EMA opinion on new pertussis vaccine

November 19, 2025
Research and Development BioNet, Vaccine

BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency …

News

1nhaler receives £1.5m in funding to develop new cardboard inhaler

November 19, 2025
Research and Development 1nhaler, asthma

1nhaler, a Scotland-based developer of drug delivery devices, has received £1.5m in seed funding for the development of its new …

News
hsm_mobile_clinical_trial_istock-872676342

Molnlycke donates risk prediction patent to SKF’s digital patent platform

November 14, 2025
Business Services Digital Platforms, Mölnlycke, SKF, The Patent Bay

Mölnlycke Health Care, a medtech company specialising in wound care and surgical solutions, has donated a risk prediction patent to …

News
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631

Study finds at-home brain stimulation therapies reduce depression relapse rate

November 14, 2025
Research and Development Brain Stimulation Therapies, Flow Neuroscience, Transcranial Direct Current Stimulation Therapy, depression

A new study published in the Journal of Affective Disorders has found that home-based, transcranial, direct current stimulation (tDCS) therapy, …

News

Smurfit Westrock unveils new clinical packaging facility at Dublin Airport

November 13, 2025
Medical Communications Dublin, Smurfit Westrock, clinical packaging facility

Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare. …

News

EVerZom enters research and licensing agreement with GENFIT

November 13, 2025
Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement

EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …

News
drug-trials

University of Birmingham scientists develop new MRI contrast agent

November 12, 2025
Research and Development Diagnostics, MRI, University of Birmingham, medical imaging

Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …

News

Custom Pharmaceuticals launches new company for drug product development

November 12, 2025
Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex

Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …

News

Novartis receives SMC approval for early breast cancer treatment

November 11, 2025
Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland

Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …

News

Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers

November 10, 2025
Manufacturing and Production Chiesi, Metered Dose Inhalers, Site Expansion, respiratory diseases

Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its manufacturing and industrial site in …

News

Richmond Pharmacology appoints Dr Edward Jackson as Medical Director

November 7, 2025
CRO, Richmond Pharmacology, biotech, clinical trials

Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …

Appointment

Vesper Bio reports positive topline results for dementia candidate

November 7, 2025
Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia

Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …

News

AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders

November 7, 2025
Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders

AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …

News

Ardena appoints new Chief Quality Officer and Chief Information Officer

November 6, 2025
Ardena, CDMO, CRO, Chief Information Officer, chief quality officer

Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO) focusing on precision medicines, …

Appointment

Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO

November 5, 2025
Draig Therapeutics, Neuropsychiatry, neuroscience

Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …

Appointment

Von Willebrand disease – increasing awareness and access to vital care

November 4, 2025
Medical Communications, Research and Development European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …

Feature

Rethinking oncology trial endpoints with generalised pairwise comparisons

November 4, 2025
Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

Feature

VALANX Biotech appoints Klaus Orlinger as Chief Scientific Officer

November 4, 2025
Antibody-Drug Conjugate, VALANX Biotech, drug development

VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …

Appointment

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

November 3, 2025
Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …

Feature

Five Facts about men’s mental health

October 31, 2025
Medical Communications Five Facts, mental health, men’s mental health

1 While only 15.4% of men are diagnosed with a common mental health condition (CMHC’s) in the UK (compared to …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025